Literature DB >> 2548934

Human papillomavirus and epithelial ovarian neoplasia.

J F Leake1, J D Woodruff, C Searle, R Daniel, K V Shah, J L Currie.   

Abstract

In contrast to the strong association between human papillomavirus (HPV) and squamous cell carcinoma of the lower female genital tract, no viral DNA had been found in epithelial ovarian carcinoma. Recently, however, R. H. Kaufman, J. Bornstein, A. N. Gordon, E. Adam, A. L. Kaplan, and K. Adler-Storthy [Gynecol. Oncol. 27, 340-349 (1987)] reported the detection of HPV-6 DNA by in situ hybridization in 10 of 12 patients with advanced epithelial ovarian carcinoma. To further investigate the possible association between HPV and epithelial ovarian neoplasia, tumor from 12 patients with epithelial ovarian adenocarcinoma, 3 with epithelial ovarian tumors of low malignant potential, and 3 with epithelial ovarian tumors of low malignant potential, and 3 with epithelial ovarian adenomas was examined for HPV DNA by the Southern hybridization technique. All the tissues were tested under low stringency for HPV-6 and under high stringency for HPV-6, HPV-16, HPV-18, HPV-31, and HPV-35. In addition, all tissues were tested by polymerase chain reaction for the presence of HPV-6 and HPV-11. Of the 12 patients with adenocarcinoma, 5 were poorly differentiated, 4 serous, 1 endometrioid, 1 mucinous, and 1 mixed. The neoplasms were of grades 2-4 with a predominance of stages III and IV (83%). Of the 3 patients with tumors of low malignant potential, all were serous and stage I. Of the 3 patients with adenomas, 1 was mucinous, 1 serous, and 1 Brenner. We were unable to detect HPV-related sequences in any of the specimens. On the basis of these findings, there appears to be no association between HPV and epithelial ovarian neoplasia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548934     DOI: 10.1016/0090-8258(89)90158-3

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Absence of human papillomavirus sequences in ovarian pathologies.

Authors:  A M Trottier; D Provencher; A M Mes-Masson; R Vauclair; F Coutlée
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

2.  Human papillomavirus genotyping and integration in ovarian cancer Saudi patients.

Authors:  Othman A Al-Shabanah; Mohamed M Hafez; Zeinab K Hassan; Mohamed M Sayed-Ahmed; Waleed N Abozeed; Salem S Al-Rejaie; Abdulmalik A Alsheikh
Journal:  Virol J       Date:  2013-11-20       Impact factor: 4.099

3.  In North America, some ovarian cancers express the oncogenes of preventable human papillomavirus HPV-18.

Authors:  Patrick Roos; Paul A Orlando; Richard M Fagerstrom; John W Pepper
Journal:  Sci Rep       Date:  2015-02-27       Impact factor: 4.379

Review 4.  The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis.

Authors:  Kasper Ingerslev; Estrid Hogdall; Tine Henrichsen Schnack; Wojciech Skovrider-Ruminski; Claus Hogdall; Jan Blaakaer
Journal:  Infect Agent Cancer       Date:  2017-05-18       Impact factor: 2.965

Review 5.  Prevalence of human papillomavirus detection in ovarian cancer: a meta-analysis.

Authors:  Soumia Cherif; Abdessamad Amine; Sarah Thies; Eliane T Taube; Elena Ioana Braicu; Jalid Sehouli; Andreas M Kaufmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-06-04       Impact factor: 3.267

6.  Detection of human papillomavirus-16 in ovarian malignancy.

Authors:  Q-J Wu; M Guo; Z-M Lu; T Li; H-Z Qiao; Y Ke
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

7.  Detection of human papillomavirus-16 e6-oncoprotein in epithelial ovarian tumors samples of iraqi patients.

Authors:  Fahem Mohsin Mahmood; Haider Sabah Kadhim; Liqaa Riadh Mousa Al Khuzaee
Journal:  Jundishapur J Microbiol       Date:  2014-09-01       Impact factor: 0.747

8.  Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients.

Authors:  Edyta Paradowska; Agnieszka Jabłońska; Mirosława Studzińska; Miłosz Wilczyński; Jacek R Wilczyński
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.